SAB Biotherapeutics, Inc. (SABS): 25-NSE filed Oct 22, 2026

Form type

25-NSE

Filing date

Oct 22, 2026

Accession number

0001354457-26-001016

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)